| Literature DB >> 26523514 |
Yupeng Dong1, Yoshitaka Kimura2, Takuya Ito3, Clarissa Velayo3, Takafumi Sato3, Rika Sugibayashi3, Kiyoe Funamoto3, Kudo Hitomi3, Keita Iida3, Miyuki Endo3, Naoaki Sato3, Nobuo Yaegashi4.
Abstract
During pregnancy, both ischemic reperfusion and bacterial agent LPS are known risk factors for fetal brain damage. However, there is a lack of evidence to explain whether vaginal LPS affects the fetus response to ischemic reperfusion. Here we reported that there was more than 2 folds higher vulnerability of fetal brain hemorrhage response to ischemic reperfusion when mother mouse was treated with vaginal LPS. As our previously reported, ischemic reperfusion induces P53-dependent fetal brain damage was based on a molecular mechanism: the transcriptional pattern was changed from HIF-1alpha-dependent to P53-dependent immediately. In the present work, only with vaginal LPS precondition, phosphorylation of activated transcriptional factor (ATF) 2 at Thr71 appeared in response to ischemic reperfusion. Moreover, this phosphorylation was completely blocked by pre-treatment with a P53 inhibitor, pifithrin-α. We concluded that vaginal LPS precondition trigged the p53-dependent phosphorylation of ATF2 in response to ischemic reperfusion, which played an important role of increasing vulnerability to hemorrhage in fetus.Entities:
Keywords: ATF2; FECG; Fetal brain hemorrhage; Ischemic reperfusion; LPS; P53
Mesh:
Substances:
Year: 2015 PMID: 26523514 DOI: 10.1016/j.bbrc.2015.10.125
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575